CompletedPhase 3NCT04838795
Sisonke (Together): OPEN LABEL TRIAL COVID-19
Studying Severe acute respiratory syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wits Health Consortium (Pty) Ltd
- Principal Investigator
- Glenda E Gray, MBChBNon-Executive Director
- Intervention
- To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine(biological)
- Enrollment
- 477102 target
- Eligibility
- 18-105 years · All sexes
- Timeline
- 2021 – 2022
Study locations (30)
- Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern Cape, South Africa
- PHOENIX Pharma Pty Ltd, Port Elizabeth, Eastern Cape, South Africa
- Josha Research, Bloemfontein, Free State, South Africa
- CRISMO Research Centre, Dr Bhekithemba, Germiston, Gauteng, South Africa
- Perinatal HIV Research Unit (PHRU), SOWETO, Johannesburg, Gauteng, South Africa
- Wits RHI: Shandukani Research Centre, Johannesburg, Gauteng, South Africa
- Themba Lethu HIV Research Unit (CHRU), Dr, Johannesburg, Gauteng, South Africa
- Synexus SA - Stanza Clinical Research Centre, Pretoria, Gauteng, South Africa
- Setshaba Research Centre,, Pretoria, Gauteng, South Africa
- Synexus Watermeyer Clinical Research Centre,, Pretoria, Gauteng, South Africa
- Ndlovu Research Centre, Pretoria, Gauteng, South Africa
- The Aurum Institute: Tembisa Clinical Research Centre, Johannesburg, Gauteng - South, South Africa
- Perinatal HIV Research Unit Kliptown, Johannesburg, Gauteng - South, South Africa
- Botha's Hill Clinical Research Site, Bothas Hill, KwaZulu-Natal, South Africa
- CAPRISA eThekwini Clinical Research Site, Dr, Durban, KwaZulu-Natal, South Africa
- +15 more locations on ClinicalTrials.gov
Collaborators
National Department of Health of South Africa · National Institute for Communicable Diseases, South Africa · KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP · Fred Hutchinson Cancer Center · Hutchinson Center Research Institute of South Africa (HCRISA) · Janssen Vaccines & Prevention B.V. · Bio Analytical Research Corporation · Dis-Chem Pharmacy · BioVac · Biocair · Right to Care · Clinical Laboratory Services
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04838795 on ClinicalTrials.govOther trials for Severe acute respiratory syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06099795Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2Centre Hospitalier Universitaire de Nīmes
- RECRUITINGPHASE4NCT06585241A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine FormulationsModernaTX, Inc.
- RECRUITINGNCT06168019Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in IndiaBoston University
- RECRUITINGEARLY PHASE1NCT05656105Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) InfectionUniversity of Alabama at Birmingham
- RECRUITINGNCT05892549COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern CharacteristicsDirection Centrale du Service de Santé des Armées
- RECRUITINGNANCT05566483Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional CapacityUniversity of Colorado, Denver
- ACTIVE NOT RECRUITINGNCT05787964Immunity to Infection in Healthy Participants and Participants With CancerUniversity Hospital Tuebingen
- RECRUITINGPHASE2, PHASE3NCT05543616A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenBioNTech SE